News Agency
Men's Weekly

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

  • Written by PR Newswire
Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer
  • ORSERDU is the first treatment specifically approved for patients with ER+, HER2- advanced or metastatic breast cancer tumors that harbor ESR1 mutations, representing the first innovation in endocrine therapy in nearly 20 years.
  • ESR1 mutations are present in up to 40% of ER+, HER2- advanced or metastatic breast cancers, and are a known driver of...

Read more: Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to...

Understanding SEO Services and Their Role in Business Growth

Boost your website’s visibility and attract the right audience with professional SEO services! Improve traffic, engagement, and results for your business.  Search engine optimisation services, widely known as SEO services, focus on improving how a website appears in search engine results... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion